[Skip to Navigation]
Sign In
Comment & Response
August 2018

Estimating and Interpreting the Overall Survival Benefit of Checkpoint Inhibitors via Meta-analysis—Reply

Author Affiliations
  • 1National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia
  • 2Graduate Institute of Oncology, National Taiwan University, Taipei, Taiwan
  • 3Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
  • 4Cancer Care Centre, St George Hospital, Sydney, New South Wales, Australia
JAMA Oncol. 2018;4(8):1138-1139. doi:10.1001/jamaoncol.2018.1105
Add or change institution